Axel A. Laminet - Concepedia

Author

Axel A. Laminet

Max Planck Institute of Biochemistry

Also Known As

A A Laminet, A. A. Laminet, Axel A. Laminet, Axel Laminet

Publications

732

Citations

H-Index

Concepts

All Affiliations

Max Planck Institute of Biochemistry New England Biolabs (United States)Boston Biomedical Research Institute Fox Chase Cancer Center Center for Molecular Medicine and Immunology

About

Axel A. Laminet is an author at Max Planck Institute of Biochemistry specializing in medicine, protein folding, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	363
2	Biochemistry	4	4	219
3	Cell Biology	3	3	93
4	Natural Sciences	2	2	44
5	Chemical Biology	1	1	22

Axel A. Laminet

Publications

674

Citations

H-Index

Page 1

	Year	Citations
The Escherichia coli heat shock proteins GroEL and GroES modulate the folding of the beta-lactamase precursor. Axel A. Laminet, Thomas Ziegelhoffer, Costa Georgopoulos, The EMBO Journal Protein FoldingVirulence FactorBacteriologyMolecular BiologyBeta-lactamase Precursor	1990	248
The precursor of beta-lactamase: purification, properties and folding kinetics. Axel A. Laminet, Andreas Plückthun The EMBO Journal Protein FoldingStructure-function Enzyme KineticsBiochemistry	1989	109
Affinity, Specificity, and Kinetics of the Interaction of the SHC Phosphotyrosine Binding Domain with Asparagine-X-X-Phosphotyrosine Motifs of Growth Factor Receptors Axel A. Laminet, Gerald Apell, Leah Conroy, Journal of Biological Chemistry	1996	70
Thermodynamic Partitioning Model for Hydrophobic Binding of Polypeptides by GroEL Ralph Zahn, Sabine E. Axmann, K P Rücknagel, Journal of Molecular Biology Polymer SolutionBiochemistryHydrophobic BindingMacromolecular SystemComputational Chemistry	1994	66
Mammalian Cell Expression of Single–Chain Fv (sFv) Antibody Proteins and Their C–terminal Fusions with Interleukin–2 and Other Effector Domains Haimanti Dorai, John E. McCartney, Robert M. Hudziak, Nature Biotechnology ImmunologyImmune RegulationMammalian Cell ExpressionAntibody ProteinsImmune Surveillance	1994	61
Engineering disulfide-linked single-chain Fv dimers [(sFv')<sub>2</sub>] with improved solution and targeting properties: anti-digoxin 26–10 (sFv')<sub>2</sub> and anti-c-erbB-2 741F8 (sFv')<sub>2</sub> made by protein folding and bonded through C-terminal cysteinyl peptides John E. McCartney, Mei-Sheng Tai, Robert M. Hudziak, Protein Engineering Design and Selection	1995	44
Targeting c-erbB-2 expressing tumors using single-chain Fv monomers and dimers. M S Tai, John E. McCartney, G P Adams, PubMed Protein AssemblyImmunologyMolecular BiologyChemical BiologyCancer Biology	1995	22
Folding in vitro and transport in vivo of pre-beta-lactamase are SecB independent. Axel A. Laminet, Carol A. Kumamoto, Andreas Plückthun PubMed	1991	22
Folding <i>in vitro</i> and transport <i>in vivo</i> of pre‐β‐lactamase are SecB independent Axel A. Laminet, Carol A. Kumamoto, Andreas Plückthun Molecular Microbiology Secb ‐ MutationAntimicrobial Resistance GeneBiochemistryProtein FoldingMedicine	1991	22
Tumor targeting in a murine tumor xenograft model with the (sFv′)2 divalent form of anti-c-erbB-2 single-chain Fv James S. Huston, Gregory P. Adams, John E. McCartney, Cell Biophysics Tumor BiologyAnti-c-erbb-2 Single-chain FvDivalent FormMedicineTumor Targeting	1994	10

Page 1